National Health Investors logo
National Health Investors NHI
$ 78.1 0.97%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

National Health Investors Income Statement 2011-2025 | NHI

Annual Income Statement National Health Investors

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.13 B 2.29 B 2.59 B 2.59 B 2.86 B 3.71 B 3.43 B 2.84 B 2.87 B 2.28 B 2.5 B 1.78 B 1.37 B 1.34 B

Shares

43.8 M 43.4 M 44.8 M 45.7 M 44.7 M 43.4 M 41.9 M 40.9 M 39 M 37.6 M 33.4 M 28.4 M 27.8 M 27.7 M

Historical Prices

71.4 52.9 57.8 56.6 64.1 70.4 61.9 58.5 54.7 42.7 46.6 35.5 34 24.9

Net Income

138 M 136 M 66.4 M 112 M 185 M 160 M 154 M 159 M 152 M 149 M 102 M 106 M - 81.1 M

Revenue

335 M 320 M 278 M 299 M 333 M 318 M 295 M 279 M 248 M 229 M 178 M 118 M - 82.7 M

Cost of Revenue

17.2 M 16.2 M 11.2 M - - - - - - - - - - -

Gross Profit

- - - - - 311 M 293 M 278 M 247 M 228 M 177 M 117 M - 82.7 M

Operating Income

- - - - - - - - - 150 M 103 M 79.5 M 74.7 M 61.9 M

Interest Expense

59.9 M 58.2 M 44.9 M 50.8 M 52.9 M 56.3 M 49.1 M 46.3 M 43.1 M 37.6 M 26.4 M 9.23 M 3.49 M 3.85 M

EBITDA

71.4 M 70 M 70.9 M 80.8 M 83.2 M 297 M 281 M 265 M 237 M 217 M 168 M 107 M - 73.8 M

Operating Expenses

212 M 201 M 242 M 216 M 162 M 90.7 M 84.2 M 79.9 M 69.8 M 64.1 M 47.4 M 30.1 M - 20.8 M

General and Administrative Expenses

20.7 M 19.3 M 22.8 M 18.4 M 13.3 M 13.9 M 12.9 M 12.7 M 10.2 M 11 M 9.32 M 10 M - 8.03 M

All numbers in USD currency

Quarterly Income Statement National Health Investors

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

47.4 M 46.7 M 45.7 M 45.7 M 43.5 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 43.4 M 44.3 M 45.7 M 45.9 M 45.9 M 45.9 M 45.9 M 45.3 M 44.9 M 44.7 M 44.7 M 44.6 M 44.1 M 43.5 M 43.2 M 42.8 M 42.4 M 42.2 M 41.7 M 41.5 M 41.5 M 41.1 M 41 M 40 M 39.8 M 39.3 M 38.5 M 38.4 M 37.7 M 37.6 M 37.6 M 37.6 M 34.3 M 33.1 M 33.1 M 33.1 M 29.8 M 27.9 M 27.9 M 27.9 M 27.8 M 27.8 M 27.8 M 27.8 M 27.7 M 27.7 M 27.7 M 27.7 M

Net Income

32.9 M 37 M 34.2 M - 28.5 M 35.3 M 30.9 M - 29.3 M 39.8 M 34.5 M - 34.5 M 21.7 M 8.4 M - 30.8 M 39.2 M 35.3 M 37.1 M 42.6 M 44.4 M 61 M 42 M 42.8 M 40 M 35.7 M 37.1 M 41 M 37.8 M 38.4 M 37.8 M 39.1 M 38.2 M 44.2 M 41.2 M 33 M 44.6 M 32.7 M 54.4 M 33.6 M 31.2 M 29.7 M 27.5 M 25.2 M 25.3 M 23.5 M 27.8 M 42.7 M 19.9 M 15.7 M 41.1 M 14.4 M 16.9 M 18.3 M 18.1 M 18.8 M 25.1 M 19.1 M

Revenue

89.8 M 90.7 M 89.3 M - 82.9 M 85 M 81.5 M - 80.1 M 77.9 M 82.4 M - 76.3 M 59.9 M 71.3 M - 73.8 M 74.3 M 6.14 M 81.3 M 6.48 M 6.26 M 6.55 M 82.2 M 6.44 M 5.52 M 5.15 M 74 M 3.23 M 3.09 M 3.49 M 71.1 M 3.15 M 4.1 M 3.09 M 65 M 3.67 M 3.31 M 3.16 M 58.6 M 2.51 M 2.52 M 2.12 M 45.7 M 1.75 M 1.75 M 1.76 M 32.8 M 1.94 M 1.97 M 1.97 M 25.9 M 1.88 M 1.85 M 1.7 M 21.5 M 1.69 M 1.63 M 1.6 M

Cost of Revenue

7.17 M 4.32 M 4.3 M - 4.3 M 4.2 M 4.23 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - - - - - - - - - - - - - - - - - - - - - - 42.8 M 40 M 35.7 M - 41 M 37.8 M 39.2 M - 39.6 M 38.3 M 34.1 M - 33.5 M 18.6 M 31.7 M - - - - - 25.5 M 25.6 M 23.9 M - 22.3 M 18.5 M 14.2 M - 13.3 M 15.9 M 17.2 M - 17.7 M 23.8 M 15.5 M

Interest Expense

13.8 M 15 M 14.3 M - 14.9 M 14.9 M 14.9 M - 15.1 M 14.2 M 14 M - 11.4 M 10.9 M 10.2 M - 12.7 M 12.8 M 13 M - 12.9 M 13.6 M 14.1 M - 14.7 M 13.7 M 13.5 M - 12.4 M 12.2 M 11.6 M - 11.7 M 11.7 M 11.7 M - 10.8 M 10.7 M 10.3 M - 9.77 M 9.29 M 8.41 M - 7 M 6.83 M 6.89 M - 3.29 M 1.6 M 1.12 M - 854 K 747 K 575 K - 1.78 M 1.59 M 477 K

EBITDA

- - - - - - - - - - - - 17.5 M 17.8 M 18.3 M - 20 M 20.7 M 20.8 M - 20.8 M 20.8 M 20.4 M - 62.4 M 59 M 54.2 M - 59.1 M 55.6 M 56.5 M - 56.6 M 55.2 M 50.3 M - 48.7 M 33.3 M 45.4 M - 13.5 M 13 M - - 25.5 M 25.6 M 23.9 M - 22.3 M 18.5 M 14.2 M - 13.3 M 15.9 M 17.2 M - 17.7 M 23.8 M 15.5 M

Operating Expenses

57.6 M 55.6 M 56 M - 54.8 M 51.8 M 51.1 M - 52 M 49.7 M 49.6 M - 56.9 M 49.6 M 66.2 M - 62.4 M 40.7 M 44.2 M - 40.9 M 38.9 M 42.6 M - 38.9 M 38.1 M 40.4 M - 33.9 M 35.1 M 33.6 M - 31.8 M 31.5 M 32.2 M - 29.8 M 42.6 M 27.3 M - 25.3 M 24.6 M 25.6 M - 18.9 M 18.6 M 19.4 M - 8.69 M 8.7 M 12.9 M - 11.1 M 5.99 M 6.84 M - 6.12 M 6.15 M 6.45 M

General and Administrative Expenses

6.31 M 6.12 M 6.83 M - 4.81 M 4.87 M 5.64 M - 4.43 M 4.31 M 5.65 M - 4.74 M 5.05 M 8.1 M - 3.65 M 3.59 M 7.99 M - 2.78 M 3.03 M 4.31 M - 2.8 M 2.97 M 4.01 M - 2.79 M 2.76 M 4.17 M - 2.51 M 2.52 M 4.11 M - 2.17 M 2.12 M 2.93 M - 1.69 M 2.51 M 3.84 M - 2.16 M 1.85 M 2.94 M - 1.76 M 2.32 M 3.09 M - 1.64 M 1.59 M 2.79 M - 1.23 M 1.29 M 3.84 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company National Health Investors (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Reit healthcare industry

Issuer Price % 24h Market Cap Country
The GEO Group The GEO Group
GEO
$ 16.54 -1.69 % $ 2.17 B usaUSA
LTC Properties LTC Properties
LTC
$ 35.03 0.89 % $ 1.53 B usaUSA
Global Medical REIT Global Medical REIT
GMRE
$ 35.3 0.57 % $ 2.33 B usaUSA
Omega Healthcare Investors Omega Healthcare Investors
OHI
$ 44.49 1.21 % $ 11.5 B usaUSA
Healthpeak Properties Healthpeak Properties
PEAK
- 2.09 % $ 9.35 B usaUSA
Ventas Ventas
VTR
$ 78.8 1.19 % $ 32.4 B usaUSA
Welltower Welltower
WELL
$ 190.7 2.13 % $ 115 B usaUSA
Sabra Health Care REIT Sabra Health Care REIT
SBRA
$ 19.18 0.03 % $ 4.48 B usaUSA